Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (Mar 14, 2018)
  • 8-K (Jan 19, 2018)
  • 8-K (Jan 17, 2018)
  • 8-K (Dec 28, 2017)
  • 8-K (Dec 11, 2017)
  • 8-K (Dec 6, 2017)

 
Other

AstroNova, Inc. 8-K 2008

Documents found in this filing:

  1. 8-K
  2. 8-K

 


UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 8-K


 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

DATE OF REPORT

(DATE OF EARLIEST EVENT REPORTED)

April 3, 2008


ASTRO-MED, INC

(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)


COMMISSION FILE NUMBER             0-13200

RHODE ISLAND

05-0318215

(STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION)

(IRS EMPLOYER IDENTIFICATION NUMBER)

 

 

 

600 EAST GREENWICH AVENUE, WEST WARWICK, RI 02893

(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES, INCLUDING ZIP CODE)

(401-828-4000)

(REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE)

 


 

ITEM 7.01. Regulation FD Disclosure

On April 3, 2008, Albert W. Ondis, Chairman and Chief Executive Officer of Astro-Med, Inc. (the “Company”), and Joseph P. O’Connell, Senior Vice President and Chief Financial Officer of the Company, presented the Company’s strategy for sustained growth and increased profitability at the B. Riley & Co. 9th Annual Las Vegas Investor Conference held at the Palms Casino Resort in Las Vegas. The presentation is posted on the Company’s website at www.astro-medinc.com, in the Investing section.

This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS

(c)

Exhibit

Exhibit no.

Exhibit

None.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned thereunto duly authorized.

 

DATE: April 3, 2008

ASTRO-MED, INC.

 

 

By: /s/ Joseph P. O’Connell         

Joseph P. O’Connell

Senior Vice President, Treasurer and Chief Financial Officer

 

 

 

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki